Logo image of OGI.CA

ORGANIGRAM GLOBAL INC (OGI.CA) Stock Fundamental Analysis

Canada - TSX:OGI - CA68617J1003 - Common Stock

2.55 CAD
-0.11 (-4.14%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

OGI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 33 industry peers in the Pharmaceuticals industry. OGI may be in some trouble as it scores bad on both profitability and health. OGI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OGI has reported negative net income.
OGI had a positive operating cash flow in the past year.
In the past 5 years OGI always reported negative net income.
In the past 5 years OGI reported 4 times negative operating cash flow.
OGI.CA Yearly Net Income VS EBIT VS OCF VS FCFOGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

OGI has a Return On Assets of 1.38%. This is amongst the best in the industry. OGI outperforms 81.82% of its industry peers.
OGI's Return On Equity of 2.02% is amongst the best of the industry. OGI outperforms 84.85% of its industry peers.
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI.CA Yearly ROA, ROE, ROICOGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

OGI has a better Profit Margin (3.47%) than 81.82% of its industry peers.
The Operating Margin and Gross Margin are not available for OGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.47%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI.CA Yearly Profit, Operating, Gross MarginsOGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OGI has been increased compared to 1 year ago.
The number of shares outstanding for OGI has been increased compared to 5 years ago.
The debt/assets ratio for OGI is higher compared to a year ago.
OGI.CA Yearly Shares OutstandingOGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI.CA Yearly Total Debt VS Total AssetsOGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

OGI has an Altman-Z score of -0.25. This is a bad value and indicates that OGI is not financially healthy and even has some risk of bankruptcy.
OGI has a Altman-Z score of -0.25. This is comparable to the rest of the industry: OGI outperforms 57.58% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that OGI is not too dependend on debt financing.
OGI's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. OGI outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.25
ROIC/WACCN/A
WACC7.89%
OGI.CA Yearly LT Debt VS Equity VS FCFOGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

OGI has a Current Ratio of 2.59. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
OGI's Current ratio of 2.59 is fine compared to the rest of the industry. OGI outperforms 69.70% of its industry peers.
OGI has a Quick Ratio of 1.42. This is a normal value and indicates that OGI is financially healthy and should not expect problems in meeting its short term obligations.
OGI's Quick ratio of 1.42 is in line compared to the rest of the industry. OGI outperforms 54.55% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.42
OGI.CA Yearly Current Assets VS Current LiabilitesOGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.88%, which is quite impressive.
The Revenue has grown by 38.86% in the past year. This is a very strong growth!
OGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%

3.2 Future

The Earnings Per Share is expected to grow by 19.93% on average over the next years. This is quite good.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 18.15% on average per year.
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.93%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGI.CA Yearly Revenue VS EstimatesOGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI.CA Yearly EPS VS EstimatesOGI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Forward Earnings ratio of 1262.38, the valuation of OGI can be described as expensive.
Based on the Price/Forward Earnings ratio, OGI is valued a bit cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. OGI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1262.38
OGI.CA Price Earnings VS Forward Price EarningsOGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI.CA Per share dataOGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
OGI's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.59%
EPS Next 3Y28.91%

More info and screens

0

5. Dividend

5.1 Amount

OGI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

TSX:OGI (10/17/2025, 7:00:00 PM)

2.55

-0.11 (-4.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)12-16 2025-12-16/amc
Inst Owners6.05%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap342.54M
Analysts77.5
Price Target3.06 (20%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)376.4%
Min EPS beat(2)-164.03%
Max EPS beat(2)916.83%
EPS beat(4)1
Avg EPS beat(4)56.27%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)3.01%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)6
Avg Revenue beat(12)-1.43%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)0%
PT rev (3m)7.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)138.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1262.38
P/S 1.53
P/FCF N/A
P/OCF 124.38
P/B 0.89
P/tB 1.21
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EY0.08%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.02
OCFY0.8%
SpS1.67
BVpS2.87
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.47%
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.48%
Cap/Sales 8.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.42
Altman-Z -0.25
F-Score3
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.93%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.15%
EBIT growth 1Y-79.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.17%
EBIT Next 3Y46.25%
EBIT Next 5Y30.62%
FCF growth 1Y78.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.64%
OCF growth 3YN/A
OCF growth 5YN/A